The full content of Annals is available to subscribers

Subscribe/Learn More  >
Original Research |

Clarithromycin-Resistant Genotypes and Eradication of Helicobacter pylori

Vincenzo De Francesco, MD; Marcella Margiotta, BSc; Angelo Zullo, MD; Cesare Hassan, MD; Laura Troiani, MD; Osvaldo Burattini, MD; Francesca Stella, MD; Alfredo Di Leo, MD; Francesco Russo, MD; Stefania Marangi, MD; Rosa Monno, MD; Vincenzo Stoppino, MD; Sergio Morini, MD; Carmine Panella, MD; and Enzo Ierardi, MD
[+] Article, Author, and Disclosure Information

From Ospedali Riuniti and University of Foggia, Foggia, Italy; University of Bari, Bari, Italy; Ospedale Nuovo Regina Margherita and “San Giacomo” Hospital, Rome, Italy; and IRCSS De Bellis, Castellana Grotte, Italy.

Grant Support: The University of Foggia provided funding for reagents, and the University of Bari provided the instruments for the real-time PCR analysis.

Potential Financial Conflicts of Interest: None disclosed.

Requests for Single Reprints: Enzo Ierardi, MD, Section of Gastroenterology, Department of Medical Sciences, University of Foggia, Ospedali Riuniti, Viale L. Pinto, 71100 Foggia, Italy; e-mail, e.ierardi@virgilio.it.

Current Author Addresses: Drs. De Francesco and Stoppino: Gastroenterology Unit, Ospedali Riuniti, Viale L. Pinto, 71100 Foggia, Italy.

Ms. Margiotta and Drs. Troiani, Burattini, Di Leo, and Marangi: Section of Gastroenterology, Department of Emergency and Organ Transplantation, University of Bari, Viale L. Ennio, 70124 Bari, Italy.

Drs. Zullo, Hassan, Stella, and Morini: Gastroenterology and Digestive Endoscopy Unit, Ospedale Nuovo Regina Margherita, Via Morosini, 00165 Rome, Italy.

Dr. Russo: Biochemistry Laboratory, IRCSS De Bellis, Viale L. Resistenza, 70100 Castellana Grotte, Italy.

Dr. Monno: Section of Hygiene, Department of Public Health, University of Bari, Viale L. Ennio, 70124 Bari, Italy.

Drs. Panella and Ierardi: Section of Gastroenterology, Department of Medical Sciences, Ospedali Riuniti, Viale L. Pinto, 71100 Foggia, Italy.

Author Contributions: Conception and design: V. De Francesco, A. Zullo, C. Hassan, E. Ierardi.

Analysis and interpretation of the data: V. De Francesco, A. Zullo, E. Ierardi.

Drafting of the article: V. De Francesco, M. Margiotta, A. Zullo, C. Hassan.

Critical revision of the article for important intellectual content: C. Hassan, E. Ierardi.

Final approval of the article: A. Di Leo, R. Monno, V. Stoppino, S. Morini, C. Panella, E. Ierardi.

Provision of study materials or patients: M. Margiotta, R. Monno.

Statistical expertise: V. De Francesco, A. Zullo.

Obtaining of funding: A. Di Leo.

Administrative, technical, or logistic support: M. Margiotta, L. Troiani, O. Burattini, F. Stella, F. Russo, S. Marangi, R. Monno.

Collection and assembly of data: M. Margiotta, C. Hassan, L. Troiani, O. Burattini, F. Stella, F. Russo, S. Marangi.

Ann Intern Med. 2006;144(2):94-100. doi:10.7326/0003-4819-144-2-200601170-00006
Text Size: A A A

Clarithromycin is the most powerful antibiotic that is currently available for H. pylori infection, and its use in first-line therapy regimens is endorsed by European and U.S. guidelines (34). Helicobacter pylori clarithromycin resistance is the main factor hampering the efficacy of standard triple therapies, and it is increasing worldwide (7). Indeed, the overall prevalence of primary clarithromycin resistance that we found (24%) would seem higher than that computed in previous Italian studies (range, 1.8% to 14.0%) (2325) and is similar to that detected in another recent study (23%) (26). We also confirm that the probability of success of a standard therapy regimen is markedly reduced by clarithromycin resistance to values less than 45%, which is similar to 2 large pooled data analyses (56) that calculated a mean eradication rate ranging from 18% to 44%.

First Page Preview

View Large
First page PDF preview


Grahic Jump Location
Flow chart showing data of patients recruited in this substudy from the previous multicenter study.

NUD = nonulcer dyspepsia; PU = peptic ulcer.

Grahic Jump Location




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $32.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.